Regenexx

Regenexx is a network of select physician experts, who pioneered the use of high concentrated PRP and bone marrow concentrate to treat common orthopedic conditions to help people avoid surgery using cells from their own bodies. Regenexx is the world leader in research published on the use of orthobiologics for orthopedic conditions and created the field of interventional orthopedic protocols, the use of your body's natural healing abilities to repair orthopedic injuries non-surgically. Regenexx created a program for self-funded employers to help manage orthopedic costs by replacing many common elective orthopedic surgeries with precise image-guided injections. Regenexx can reduce the cost of individual surgeries by up to 70%. Learn more about Regenexx and how they help employers take control of their health care spending. Visit www.Regenexxcorporate.com for more information.

News & Updates:

Regenexx® Achieves Nearly Fifty Percent Cost Savings by Surgery Avoidance, According to Report by Validation Institute  
2022 Validation Report 
The Validation Institute Reviews Regenexx Cost Savings

Year-end timing:  10.1 and 1.1 of every year tend to be our busiest times and processing can back up.  If you are aware of a potential client adding Regenexx, please keep in mind that it can take up to six weeks to go live.  Even if something comes in late, we will do our best to make it happen but the later it gets means there is a risk of a live date slipping by a small amount.

Next general Regenexx Overview:  How Advisors and Self-Funded employers are effectively using Regenexx as an MSK cost control solution: August 9th, 1:00 p.m. Mountain Time.  Click here to register.

 

Contact:

Marc Gillotti, EVP
303.408.9908 
mgillotti@Regenexx.com